亚太地区血脑屏障技术市场预测至 2028 年 - COVID-19 影响和区域技术分析(双特异性抗体 RMT 方法、特洛伊木马方法、增加渗透性、被动扩散和其他非侵入性 BBB 技术)和应用(阿尔茨海默氏症™)病、癫痫、帕金森病、多发性硬化症、亨特综合症、脑癌等)

TIPRE00026225 | Pages: 130 | Biotechnology | Dec 2021 | Type: Regional | Status: Published

市场介绍

基于中国等国家分析亚太血脑屏障技术市场、日本、印度、澳大利亚、韩国和亚太地区其他地区。亚太地区预计将成为所有其他地区中增长最快的地区。由于患者群体庞大、对神经退行性疾病的认识不断提高、技术进步以及亚太地区发展中国家研发不断增长等因素,该地区市场的增长预计将以更快的速度增长。此外,发展医疗基础设施和增加投资以提高制造能力预计将在预测期内推动亚太地区血脑屏障技术市场的发展。

截至 2021 年 9 月,新冠疫情根据联合国人道主义事务协调办公室 (UNOCHA) 的数据,亚太地区 -19 例病例达到 5650 万例。根据在亚洲进行的几项研究,COVID-19 还会攻击大脑,可能导致全身或局灶性神经系统表现。据报道,COVID-19 感染还可表现出多种神经系统表现,如失味、嗅觉丧失或味觉障碍,并导致中风、脑病、格林-巴利综合征等神经系统疾病。新的证据表明,SARS-CoV-2 除呼吸系统外还可影响中枢神经系统 (CNS)。科学家在多个器官中检测到 SARS-CoV-2 RNA,包括 COVID-19 患者死后脑组织。最近对 COVID-19 患者进行尸检后的一项研究表明,皮质神经元中存在 SARS-CoV-2。此外,人脑类器官的结果也说明了SARS-CoV-2的神经侵袭能力。总之,这些数据为人类中枢神经系统感染 SARS-CoV-2 提供了证据,但该病毒如何侵入大脑仍未被发现。在少数研究中,观察到 SARS-CoV-2 病毒的刺突蛋白也在多个模型中穿过血脑屏障。因此,由于 COVID-19 的影响,该地区的血脑屏障技术市场出现了显着扩张。

市场概况和动态

亚太地区血脑屏障技术市场预计将从2021年的2.2198亿美元增长到2028年的11.2304亿美元;预计 2021 年至 2028 年复合年增长率为 26.1%。神经系统疾病,如癫痫和惊厥、帕金森病、痴呆、自闭症、阿尔茨海默病、脑肿瘤和脑瘫等,会影响人类的大脑和神经。人体。癫痫是一种非传染性慢性脑部疾病,影响所有年龄段的人。据世界卫生组织 (WHO) 统计,全球约有 5000 万人患有癫痫症,使其成为世界上最常见的神经系统疾病之一。近 80% 的癫痫患者生活在低收入和中等收入国家。同一消息来源估计,通过正确的诊断和治疗,高达 70% 的癫痫患者可以无癫痫发作。痴呆症目前是所有疾病中第七大死因,也是全世界老年人残疾和成瘾的主要原因之一。据世界卫生组织称,全球有超过 5500 万人患有痴呆症,并且每年新增近 1000 万例痴呆症病例。痴呆症是由多种主要或继发影响大脑的疾病和损伤引起的。阿尔茨海默病是最常见的痴呆症,可能导致 60% 至 70% 的痴呆症病例。因此,神经系统疾病的日益流行需要先进的血脑屏障技术进行治疗,预计将在预测期内推动市场发展。

Key细分市场

从技术角度来看,增加渗透性细分市场占据亚太血液市场最大份额2021年血脑屏障技术市场。从应用来看,帕金森病细分市场占据2021年亚太血脑屏障技术市场的最大份额。

主要来源和上市公司

准备时参考的一些主要一手和二手来源这份关于亚太地区血脑屏障技术市场的报告包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有梯瓦制药工业有限公司(Teva Pharmaceutical Industries Ltd.); F.霍夫曼-拉罗氏有限公司;礼来公司;百时美施贵宝公司;辉瑞公司;强生公司约翰逊服务公司;和 JCR Pharmaceuticals Co., Ltd. 等

购买报告的理由

  • 了解亚太地区血脑屏障技术市场格局并确定最有可能的细分市场确保丰厚的回报
  • 了解亚太血脑屏障技术市场不断变化的竞争格局,保持领先地位
  • 通过确定最有可能销售前景的细分市场,有效规划亚太血脑屏障技术市场的并购和合作交易
  • 帮助做出明智的业务决策通过对亚太血脑屏障技术市场各个细分市场表现的敏锐和全面的分析
  • 获得亚太地区2021-2028年各个细分市场的市场收入预测.

亚太地区血脑屏障技术市场细分

亚太血脑屏障技术市场 –按技术

  • 双特异性抗体RMT方法
  • 特洛伊木马方法
  • 增加渗透性
  • 被动扩散
  • 其他非侵入性 BBB 技术

亚太血脑屏障技术市场 -通过应用

  • 阿尔茨海默病
  • 癫痫
  • 帕金森病
  • 多发性硬化症
  • 猎人综合症
  • 脑癌
  • 其他
  • >

亚太血脑屏障技术市场 –按国家/地区

  • 中国
  • 日本
  • 印度
  • 澳大利亚
  • 韩国
  • 亚太地区其他地区

亚太血脑屏障技术市场 -提及的公司

  • 梯瓦制药工业有限公司                             ;       
  • F.霍夫曼拉罗氏有限公司                    ;           
  • 礼来公司和公司      ;                      ;                     ;            
  • 百时美施贵宝公司                         ;                   
  • 辉瑞公司                                    ;                     ;              
  • 强生公司约翰逊服务公司                  ;                   
  • JCR制药有限公司

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Blood Brain Barrier Technologies Market – By Technology

1.3.2        Asia Pacific Blood Brain Barrier Technologies Market – By Application

1.3.3        Asia Pacific Blood Brain Barrier Technologies Market– By Country

2.           Asia Pacific Blood Brain Barrier Technologies Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Blood Brain Barrier Technologies Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           Asia Pacific Blood Brain Barrier Technologies Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Elevating Prevalence of Neurological Disorders

5.1.2        Boosting Geriatric Population and Rising Prevalence of Age-Associated Neurological Disorders

5.2         Market Restraints

5.2.1        Concerns in Brain Medication Delivery

5.3         Market Opportunities

5.3.1        Huge Number of Product Approvals and Launches

5.4         Future Trends

5.4.1        Growing Demand of Nanoparticles for Brain Drug Delivery

5.5         Impact Analysis

6.           Asia Pacific Blood Brain Barrier Technologies – Market Analysis

6.1         Asia Pacific Blood Brain Barrier Technologies Market Revenue Forecast and Analysis

7.           Asia Pacific Blood Brain Barrier Technologies Market Analysis – by Technology

7.1         Overview

7.2         Blood Brain Barrier Technologies Market, by Technology 2021 & 2028 (%)

7.3         Bispecific Antibody RMT Approach

7.3.1        Overview

7.3.2        Bispecific Antibody RMT Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Trojan Horse Approach

7.4.1        Overview

7.4.2        Trojan Horse Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Increasing Permeability

7.5.1        Overview

7.5.2        Increasing Permeability: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Passive Diffusion

7.6.1        Overview

7.6.2        Passive Diffusion: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

7.7         Other Non-Invasive BBB Technologies

7.7.1        Overview

7.7.2        Other Non-Invasive BBB Technologies: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.           Asia Pacific Blood Brain Barrier Technologies Market Analysis – By Application

8.1         Overview

8.2         Blood Brain Barrier Technologies Market, by Application 2021 & 2028 (%)

8.3         Alzheimer’s Disease

8.3.1        Overview

8.3.2        Alzheimer’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Epilepsy

8.4.1        Overview

8.4.2        Epilepsy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Parkinson’s Disease

8.5.1        Overview

8.5.2        Parkinson’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Multiple Sclerosis

8.6.1        Overview

8.6.2        Multiple Sclerosis: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Hunter’s Syndrome

8.7.1        Overview

8.7.2        Hunter’s Syndrome: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.8         Brain Cancer

8.8.1        Overview

8.8.2        Brain Cancer: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.9         Others

8.9.1        Overview

8.9.2        Others: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

9.           Asia Pacific Blood Brain Barrier Technologies Market – Country Analysis

9.1         Overview

9.1.1        Asia Pacific: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)

9.1.1.1          China: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.1          China: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.2          China: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.3          China: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.1.1.2          Japan: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.2.1          Japan: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.2.2          Japan: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.1.1.2.3          Japan: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.1.1.3          India: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.1          India: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.2          India: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.3          India: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.1.1.4          South Korea: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.4.1          South Korea: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.4.2          South Korea: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.1.1.4.3          South Korea: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.1.1.5          Australia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.5.1          Australia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.5.2          Australia: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.1.1.5.3          Australia: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.1.1.6          Rest of Asia Pacific: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.6.1          Rest of Asia Pacific: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.6.2          Rest of Asia Pacific: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.1.1.6.3          Rest of Asia Pacific: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

10.        Impact Of COVID-19 Pandemic on Asia Pacific Blood Brain Barrier Technologies Market

10.1      Impact Assessment of COVID-19 Pandemic

11.        Asia Pacific Blood Brain Barrier Technologies Market– Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Teva Pharmaceutical Industries Ltd.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      F. Hoffmann-La Roche Ltd.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Eli Lilly and Company

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Bristol-Myers Squibb Company

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Pfizer, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Johnson and Johnson Services, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      JCR Pharmaceuticals Co., Ltd.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Asia Pacific Blood Brain Barrier Technologies Market – Revenue, and Forecast to 2028 (US$ Million)

Table 2.             China: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 3.             China: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             Japan: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 5.             Japan: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 6.             India: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 7.             India: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8.             South Korea: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 9.             South Korea: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 10.          Australia: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 11.          Australia: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12.          Rest of Asia Pacific: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of Asia Pacific: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 14.          Organic Developments Done By Companies

Table 15.          Inorganic Developments Done By Companies

Table 16.          Glossary of Terms, Blood Brain Barrier Technologies Market

 


LIST OF FIGURES

Figure 1.           Asia Pacific Blood Brain Barrier Technologies Market Segmentation

Figure 2.           Blood Brain Barrier Technologies Market Segmentation, By Country

Figure 3.           Asia Pacific Blood Brain Barrier Technologies Market Overview

Figure 4.           Increasing Permeability Segment Held the Largest Share by Technology in Blood Brain Barrier Technologies Market

Figure 5.           India to Show Significant Growth During Forecast Period

Figure 6.           Asia Pacific Blood Brain Barrier Technologies Market, Industry Landscape

Figure 7.           Asia Pacific PEST Analysis

Figure 8.           Asia Pacific Blood Brain Barrier Technologies Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 9.           Blood Brain Barrier Technologies Market, by Technology 2021 & 2028 (%)

Figure 10.        Bispecific Antibody RMT Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Trojan Horse Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Increasing Permeability: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Passive Diffusion: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Other Non-Invasive BBB Technologies: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Blood Brain Barrier Technologies Market, by Application 2021 & 2028 (%)

Figure 16.        Alzheimer’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Epilepsy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Parkinson’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Multiple Sclerosis: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Hunter’s Syndrome: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Brain Cancer: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Others: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Asia Pacific: Blood Brain Barrier Technologies Market, by Key Country – Revenue (2021) (USD Million)

Figure 24.        Asia Pacific: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)

Figure 25.        China: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        Japan: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        India: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        South Korea: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        Australia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Rest of Asia Pacific: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.          Impact of COVID-19 Pandemic on Asia Pacific Country Markets
  1. Teva Pharmaceutical Industries Ltd.                                         
  2. F. Hoffmann-La Roche Ltd                                                            
  3. Eli Lilly and Company                                                                    
  4. Bristol-Myers Squibb Company                                                    
  5. Pfizer, Inc.                                                                                       
  6. Johnson & Johnson Services, Inc.                                               
  7. JCR Pharmaceuticals Co., Ltd
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific blood brain barrier technologies market.                                      
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific blood brain barrier technologies market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the blood brain barrier technologies market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000